CEFTAZIDIME - Food and Drug Administration
- Manufacturer
- Food and Drug Administration
- Effective date
- 2015-04-09
- Label type
- Indexing - product concept
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-05 00:16:05
Label at a glance#
ProductCEFTAZIDIME
Active ingredientCEFTAZIDIME, AVIBACTAM SODIUM
Products#
Every source-derived product name is available through these pages.
- CEFTAZIDIME
- CEFTAZIDIME ANHYDROUS
- AVIBACTAM SODIUM
- AVIBACTAM
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CEFTAZIDIME | 9M416Z9QNR | ACTIM |
| AVIBACTAM SODIUM | 9V824P8TAI | ACTIM |
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ceftazidime | CEFTAZIDIME | Sagent Pharmaceuticals | 112c5457-8d71-49f5-b531-9761d7d38c93 | 2026-08-03 | Warnings, Adverse reactions | Ceftazidime CEFTAZIDIME |
| TAZICEF | CEFTAZIDIME | Hospira, Inc. | 40d48c5d-650e-461b-a67b-7e65772d1b92 | 2026-05-04 | Warnings, Adverse reactions | CEFTAZIDIME |
| TAZICEF | CEFTAZIDIME | Hospira, Inc. | 1ab5ae3e-e303-4499-4c89-472d7cc1e46c | 2024-07-04 | Warnings, Adverse reactions | CEFTAZIDIME |
| Ceftazidime | CEFTAZIDIME | Sagent Pharmaceuticals | aec64360-8452-4987-a366-a5a4f8762ab6 | 2024-01-03 | Warnings, Adverse reactions | Ceftazidime CEFTAZIDIME |
| Ceftazidime | CEFTAZIDIME | WG Critical Care, LLC | bcc81df2-20e3-4738-bfcf-301da883c1d9 | 2023-09-11 | Warnings, Adverse reactions | Ceftazidime CEFTAZIDIME |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.